Bioprocessing and biomanufacturing focus
Latest
ReportPharma Horizons: Nitrosamines
EPR’s 2026 nitrosamines report covers the key developments in manufacturing, quality, regulation, analytical development and beyond.
WebinarRegulatory shifts ahead: preparing for EU pharmaceutical reform and FDA changes
With the EU’s pharmaceutical legislation reform soon to come into force, regulatory experts outline what is changing across both US and European frameworks and how sponsors can position pipelines ahead of implementation.
ArticleTroubleshooting capping defects in brittle tablet formulations
Cam-driven technology optimises the compaction process by maintaining consistent tablet hardness across turret speeds, enabling robust, scalable manufacturing of capping-prone blends.
Featured
Article
Movement, speed and numbers: contribution of cleanroom operators to particle control
Tim Sandle explores the main factors that influence particle accumulation in pharmaceutical cleanrooms, advising how best to control risks and minimise operator contamination.
Article
CHO perfusion model lifts yield by letting cellular waste build up
A hybrid model built into commercial software and running a self-driving bioreactor has found that unmeasured cellular waste, not the usual metabolites, throttles perfusion yields.
Webinars
- Previous
- Next
Whitepapers
- Previous
- Next
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
More bioprocessing and biomanufacturing
ReportPharma Horizons: Process Analytical Technology (PAT)
The definitive guide to transitioning from manual, offline batch testing to automated, continuous biomanufacturing.
- Article
Troubleshooting capping defects in brittle tablet formulations
Cam-driven technology optimises the compaction process by maintaining consistent tablet hardness across turret speeds, enabling robust, scalable manufacturing of capping-prone blends.
ArticleWhat Annex 22 spells for AI in GMP manufacturing
Europe’s first dedicated framework for artificial intelligence in GMP manufacturing is close to finalisation and it is more demanding and more consequential than many manufacturers may currently appreciate.
ArticleStaying competitive within the evolving CDMO model
CEO of Lupin Manufacturing Solutions, shares his perspective on what differentiates credible CDMO entrants as pharmaceutical pipelines shift towards structurally complex molecules.
ArticleDay three preview: the Future of Bio/Pharma Analysis Virtual Summit 2026
Pharmaceutical manufacturing takes centre stage on Day three of The Future of Bio/Pharmaceutical Analysis Virtual Summit 2026 as speakers examine how digital technologies, artificial intelligence and advanced production methods are reshaping what is possible in the field.
ArticleImplementing horizontal recycling for pharmaceutical release liners
Closed-loop backing paper recycling enables manufacturers to convert release liner waste into circular materials without modifications to existing printers or labellers, meanwhile ensuring EU packaging waste regulation compliance.
ArticleThermal assurance as an operating model: why the pharmaceutical cold chain must evolve beyond visibility
Real-time monitoring has become standard practice in temperature-controlled distribution. The differentiator now is whether organisations can convert signals into decisions early enough to prevent excursions, reduce waste and strengthen resilience. As Vijay Paliwal, Vice President, Global Advanced Solutions & Customer Experience at Cold Chain Technologies explains, that shift is driving a new operating model for cold chain management: thermal assurance.
ArticleMedicines as strategic assets: the new politics of pharma supply
Ahead of CPHI Americas in June, Sherma Ellis Daal explores how informed, cross-sector dialogue in the pharmaceutical supply chain can help navigate an increasingly complex global system.
ArticleBreaking the biomanufacturing mould: a patient-centric CDMO approach
Helen Bickley, Chief Quality Officer, FUJIFILM Biotechnologies reveals a new agile approach to biologics production that adopts a modular strategy for greater flexibility and ease.
ReportPharma Horizons: Cell and Gene Therapy
EPR’s 2026 cell and gene therapy report covers the key developments in manufacturing, regulation, drug delivery, process development and beyond.
OpinionReal-time Raman spectroscopy closes bioprocess control measurement gap
Manual sampling cycles leave bioreactor control decisions hours behind culture dynamics. Process Raman spectroscopy offers continuous, real-time measurement of critical parameters, enabling true closed-loop control in perfusion and continuous bioprocessing applications where measurement lag directly impacts yield and product quality.
OpinionProcess Raman spectroscopy: closing biomanufacturing’s measurement infrastructure gap
The biopharmaceutical industry has embraced Pharma 4.0 concepts, but the measurement infrastructure required to realise autonomous facilities and continuous bioprocessing remains underdeveloped. Process Raman spectroscopy offers continuous, non-destructive monitoring at frequencies aligned with cell culture dynamics, bridging the gap between control system capabilities and available data.
ArticleEuropean Pharmaceutical Review Issue 1 (2026): Environmental Monitoring In-Depth Focus
This In-Depth Focus explores how BPCs, RMMs and AI-enabled analytics are being evaluated as a tool to enhance aseptic manufacturing, bioburden testing and monitoring.
ArticleRaman spectroscopy market reaches $2.35bn driven by pharma
A recent market report projecting the combined NIR and Raman spectroscopy sector will reach $2.35 billion in 2026 underscores the rapid adoption of vibrational spectroscopy across biopharmaceutical manufacturing, with AI-enhanced Raman tools increasingly being deployed for real-time quality control.
ArticleEuropean Pharmaceutical Review Issue 1 2026
EPR Issue 1 includes articles on manufacturing, drug delivery, environmental monitoring, analytical techniques and more.